OPC Pharmaceutical Joint Stock Company reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was VND 323,451.91 million compared to VND 298,639.77 million a year ago. Net income was VND 24,529.3 million compared to VND 35,572.67 million a year ago.
For the full year, revenue was VND 1,008,160.83 million compared to VND 1,171,614.11 million a year ago. Net income was VND 122,297.17 million compared to VND 142,127.93 million a year ago. Basic earnings per share from continuing operations was VND 1,635 compared to VND 1,994 a year ago. Diluted earnings per share from continuing operations was VND 1,635 compared to VND 1,994 a year ago.